Decheng Capital Global Life Sciences Fund IV, L.P. has filed 12 insider transactions across 2 companies since January 2024.
Most recent transaction: a transaction of 2333887 shares of Aardvark Therapeutics, Inc. ($AARD) on February 14, 2025.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | Aardvark Therapeutics, Inc. | $AARD | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Common Stock | 2333887 | $0.00 | 3,292,299.0000 | 0 | 243.52% | 0.00% |
| Feb. 14, 2025 | Aardvark Therapeutics, Inc. | $AARD | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Common Stock | 333412 | $0.00 | 3,292,299.0000 | 0 | 11.27% | 0.00% |
| Feb. 14, 2025 | Aardvark Therapeutics, Inc. | $AARD | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | P | Common Stock | 625000 | $16.00 | 3,917,299.0000 | 0 | 18.98% | 0.00% |
| Feb. 14, 2025 | Aardvark Therapeutics, Inc. | $AARD | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | P | Common Stock | 625000 | $16.00 | 3,917,299.0000 | 0 | 18.98% | 0.00% |
| Feb. 14, 2025 | Aardvark Therapeutics, Inc. | $AARD | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Series C Convertible Preferred Stock | 19777363 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Aardvark Therapeutics, Inc. | $AARD | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Series C Convertible Preferred Stock | 2825337 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 29, 2024 | CG Oncology, Inc. | $CGON | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | P | Common Stock | 400000 | $19.00 | 4,958,810.0000 | 0 | 8.77% | 0.00% |
| Jan. 29, 2024 | CG Oncology, Inc. | $CGON | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Common Stock | 3628198 | $0.00 | 4,958,812.0000 | 0 | 272.67% | 0.00% |
| Jan. 29, 2024 | CG Oncology, Inc. | $CGON | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | P | Common Stock | 400000 | $19.00 | 4,958,812.0000 | 0 | 8.77% | 0.00% |
| Jan. 29, 2024 | CG Oncology, Inc. | $CGON | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Series C Preferred Stock | 8644891 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 29, 2024 | CG Oncology, Inc. | $CGON | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Series E Preferred Stock | 21547685 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 29, 2024 | CG Oncology, Inc. | $CGON | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Series F Preferred Stock | 4402320 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |